Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes

Kam Sing Ho, Jacqueline Sheehan, James Salonia
European Respiratory Journal 2019 54: PA2916; DOI: 10.1183/13993003.congress-2019.PA2916
Kam Sing Ho
1Icahn School of Medicine at Mount Sinai, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kam.ho@mountsinai.org
Jacqueline Sheehan
1Icahn School of Medicine at Mount Sinai, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Salonia
1Icahn School of Medicine at Mount Sinai, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

We determine the rate of hospital readmission within 30 days of non-ventilator hospital acquired pneumonia (NV-HAP) and its impact on mortality, morbidity, and health care use in the United States. A retrospective study was conducted using the Agency for Healthcare Research and Quality’s Healthcare Cost and Utilization Project Nationwide Readmission Database for the year 2014 (14.9 million hospital stays at 2048 hospitals in 22 states).

86,601 adulthospital admissions were identified for NV-HAP and discharged. The primary outcome was rate of all-cause readmission within 30 days of discharge. Secondary outcomes were reasons for readmission, readmission mortality rate, morbidity (shock and prolonged mechanical ventilation) and resource use (length of stay and total hospitalization costs and charges). Independent risk factors for readmission were identified using logistic regression analysis.

The 30-day rate of readmission was 12.6%. 51%of readmissions were due to recurrent Pneumonia, followed by sepsis (40%). The rate of death among patients readmitted to the hospital (21%) was lower than that for index admissions (26%) (P<.01). A total of 189,293 hospital days was associated with readmission, and the total health care in-hospital economic burden was $426 million (in costs) and $1.57 billion (in charges). Independent predictors of readmission were advanced age, income, insurance, discharged from university hospitals, discharge to rehabilitation facility, and advanced Charlson comorbidity index.

In this retrospective study of patients hospitalized for NV-HAP, readmission is associated with a high mortality, morbidity, and resource use.

  • Pneumonia
  • Adults
  • Sepsis

Footnotes

Cite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA2916.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2019
Previous
Back to top
Vol 54 Issue suppl 63 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes
Kam Sing Ho, Jacqueline Sheehan, James Salonia
European Respiratory Journal Sep 2019, 54 (suppl 63) PA2916; DOI: 10.1183/13993003.congress-2019.PA2916

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes
Kam Sing Ho, Jacqueline Sheehan, James Salonia
European Respiratory Journal Sep 2019, 54 (suppl 63) PA2916; DOI: 10.1183/13993003.congress-2019.PA2916
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Ultrasound diaphragm activity in patients with cystic fibrosis: relationship to disease severity and peripheral muscle strength
  • Pleural Effusion in Patients with Community Acquired Pneumonia
  • Late Breaking Abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patients
Show more Respiratory infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society